US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 2.610
  • +0.030+1.16%
Trading Apr 24 12:47 ET
378.69MMarket Cap-1673P/E (TTM)

About Adaptive Biotechnologies Company

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Company Profile

SymbolADPT
Company NameAdaptive Biotechnologies
Listing DateJun 27, 2019
Issue Price20.00
Founded2009
CEOMr. Chad Robins
MarketNASDAQ
Employees709
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1165 Eastlake Avenue East
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-659-0067

Company Executives

  • Name
  • Position
  • Salary
  • Chad M. Robins
  • Chairman of the Board and Chief Executive Officer
  • 8.85M
  • Dr. Sharon Benzeno, PhD
  • Chief Commercial Officer, Immune Medicine
  • 3.24M
  • R Mark Adams
  • Chief Operating Officer
  • --
  • Julie Rubinstein
  • President and Chief Operating Officer
  • 6.54M
  • Dr. Harlan Robins, PhD
  • Chief Scientific Officer
  • 8.46M
  • Kyle Piskel
  • Chief Financial Officer and Principal Accounting Officer
  • 1.66M
  • Francis Lo
  • Chief People Officer
  • --
  • Stacy L. Taylor
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Peter M. Neupert
  • Lead Independent Director
  • 341.33K
  • Michelle Griffin
  • Independent Director
  • 316.33K
  • Katey Einterz Owen
  • Independent Director
  • 296.33K
  • Dr. Robert M. Hershberg, M.D.,PhD
  • Independent Director
  • 311.33K
  • Dr. Michael J. Pellini,M.D.
  • Independent Director
  • 296.33K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg